These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15892884)

  • 21. Positive associations of polymorphisms in the metabotropic glutamate receptor type 8 gene (GRM8) with schizophrenia.
    Takaki H; Kikuta R; Shibata H; Ninomiya H; Tashiro N; Fukumaki Y
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):6-14. PubMed ID: 15211621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.
    Tsunoka T; Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Okumura T; Inada T; Ozaki N; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):875-9. PubMed ID: 19386277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between genetic variants of the metabotropic glutamate receptor 3 (GRM3) and cognitive set shifting in healthy individuals.
    Baune BT; Suslow T; Beśte C; Birosova E; Domschke K; Sehlmeyer C; Konrad C
    Genes Brain Behav; 2010 Jul; 9(5):459-66. PubMed ID: 20132315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics.
    Sanders AR; Duan J; Levinson DF; Shi J; He D; Hou C; Burrell GJ; Rice JP; Nertney DA; Olincy A; Rozic P; Vinogradov S; Buccola NG; Mowry BJ; Freedman R; Amin F; Black DW; Silverman JM; Byerley WF; Crowe RR; Cloninger CR; Martinez M; Gejman PV
    Am J Psychiatry; 2008 Apr; 165(4):497-506. PubMed ID: 18198266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association analysis of the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.
    Bishop JR; Wang K; Moline J; Ellingrod VL
    Psychiatr Genet; 2007 Dec; 17(6):358. PubMed ID: 18075480
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
    Carroll LS; Williams NM; Moskvina V; Russell E; Norton N; Williams HJ; Peirce T; Georgieva L; Dwyer S; Grozeva D; Greene E; Farmer A; McGuffin P; Morris DW; Corvin A; Gill M; Rujescu D; Sham P; Holmans P; Jones I; Kirov G; Craddock N; O'Donovan MC; Owen MJ
    Mol Psychiatry; 2010 Nov; 15(11):1101-11. PubMed ID: 19786960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophrenia.
    Nunokawa A; Watanabe Y; Kitamura H; Kaneko N; Arinami T; Ujike H; Inada T; Iwata N; Kunugi H; Itokawa M; Ozaki N; Someya T
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):239-40. PubMed ID: 18412850
    [No Abstract]   [Full Text] [Related]  

  • 28. Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia.
    Shibata H; Joo A; Fujii Y; Tani A; Makino C; Hirata N; Kikuta R; Ninomiya H; Tashiro N; Fukumaki Y
    Psychiatr Genet; 2001 Sep; 11(3):139-44. PubMed ID: 11702055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia.
    Sato J; Shimazu D; Yamamoto N; Nishikawa T
    J Neural Transm (Vienna); 2008 Sep; 115(9):1355-65. PubMed ID: 18665322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.
    Fijal BA; Kinon BJ; Kapur S; Stauffer VL; Conley RR; Jamal HH; Kane JM; Witte MM; Houston JP
    Pharmacogenomics J; 2009 Oct; 9(5):311-8. PubMed ID: 19451915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.
    García-Bea A; Walker MA; Hyde TM; Kleinman JE; Harrison PJ; Lane TA
    Schizophr Res; 2016 Nov; 177(1-3):18-27. PubMed ID: 27130562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment.
    Bishop JR; Ellingrod VL; Moline J; Miller D
    Schizophr Res; 2005 Sep; 77(2-3):253-60. PubMed ID: 15913960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.
    Thiselton DL; Vladimirov VI; Kuo PH; McClay J; Wormley B; Fanous A; O'Neill FA; Walsh D; Van den Oord EJ; Kendler KS; Riley BP
    Biol Psychiatry; 2008 Mar; 63(5):449-57. PubMed ID: 17825267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population.
    Tsunoka T; Kishi T; Kitajima T; Okochi T; Okumura T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Inada T; Ujike H; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):639-44. PubMed ID: 20211215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population.
    Martí SB; Cichon S; Propping P; Nöthen M
    Am J Med Genet; 2002 Jan; 114(1):46-50. PubMed ID: 11840505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GRM7 polymorphisms and risk of schizophrenia in Iranian population.
    Azari I; Moghadam RH; Fallah H; Noroozi R; Ghafouri-Fard S; Taheri M
    Metab Brain Dis; 2019 Jun; 34(3):847-852. PubMed ID: 30610437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP.
    Sartorius LJ; Weinberger DR; Hyde TM; Harrison PJ; Kleinman JE; Lipska BK
    Neuropsychopharmacology; 2008 Oct; 33(11):2626-34. PubMed ID: 18256595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex.
    Marenco S; Steele SU; Egan MF; Goldberg TE; Straub RE; Sharrief AZ; Weinberger DR
    Am J Psychiatry; 2006 Apr; 163(4):740-2. PubMed ID: 16585454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for association between a non-synonymous polymorphism in the gene encoding human metabotropic glutamate receptor 7 and schizophrenia.
    Bray NJ; Williams NM; Bowen T; Cardno AG; Gray M; Jones LA; Murphy KC; Sanders RD; Spurlock G; Odonovan MC; Owen MJ
    Psychiatr Genet; 2000 Jun; 10(2):83-6. PubMed ID: 10994646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations.
    Ma J; Qin W; Wang XY; Guo TW; Bian L; Duan SW; Li XW; Zou FG; Fang YR; Fang JX; Feng GY; Gu NF; St Clair D; He L
    Mol Psychiatry; 2006 May; 11(5):479-87. PubMed ID: 16402132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.